scholarly journals Randomised Phase II Study of Axitinib or Bevacizumab Combined with Paclitaxel/Carboplatin (PAC/CARB) as First-Line Therapy for Patients (PTS) with Advanced Non–Small Cell Lung Cancer (NSCLC)

2012 ◽  
Vol 23 ◽  
pp. ix408
Author(s):  
C. Twelves ◽  
E. Chmielowska ◽  
L. Havel ◽  
S. Popat ◽  
A. Swieboda-Sadlej ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

2006 ◽  
Vol 61 (2) ◽  
pp. 143
Author(s):  
Ki Eun Hwang ◽  
So Young Kim ◽  
Jong Hoon Jung ◽  
Seong Hoon Park ◽  
Jung Hyun Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Final Results of a Phase II Study of Bevacizumab, Cisplatin and Pemetrexed as First-Line Therapy for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

2016 ◽  
Vol 07 (07) ◽  
pp. 455-463
Author(s):  
Guillermo López Vivanco ◽  
Eider Azkona ◽  
Sergio Carrera ◽  
Aintzane Sancho ◽  
Itziar Rubio ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer

2008 ◽  
Vol 25 (3) ◽  
pp. 303-308 ◽  
Author(s):  
Eleni M. Karapanagiotou ◽  
Adrianni Charpidou ◽  
Ifigenia Tzannou ◽  
Kalliopi Dilana ◽  
Elias Kotteas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Final results of a phase II study of bevacizumab, cisplatin and pemetrexed as first-line therapy for patients with advanced non squamous non small cell lung cancer.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19036-e19036
Author(s):  
Guillermo Lopez Vivanco ◽  
Sergio Carrera ◽  
Itziar Rubio ◽  
Eider Azcona ◽  
Aintzane Sancho ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document